Skip to content
healthcare.dev
Get a free key

HARLIKU

NDC 70709-112, nitisinone, tablet, from Cycle Pharmaceuticals Ltd..

Product NDC
70709-112
Status
Listed
Labeler
Cycle Pharmaceuticals Ltd.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209449
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70709-112 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NITISINONE2 mg/1

Pharmacologic classes

4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2E1 Inducers [MoA]; Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]

Package NDCNDC-11Package
70709-112-60707090112601 BOTTLE, PLASTIC in 1 CARTON (70709-112-60) / 60 TABLET in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7cf67e24-d46b-4376-bbd0-0b973c406d0d

Use it

Look up 70709-112 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70709-112 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70709-112. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.